NCT05002738View on ClinicalTrials.gov

Desogestrel-containing COCP Pharmacokinetic Validation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

November 28, 2022

Study Completion Date

November 28, 2022

Conditions
Contraception
Interventions
DRUG

Desogestrel and Ethinyl Estradiol Tablets

Combined oral contraceptive pill

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT05002738 - Desogestrel-containing COCP Pharmacokinetic Validation Study | Biotech Hunter | Biotech Hunter